1. Zetia showed no clinical benefit when added to Zocor in the ENHANCE study, despite raising HDL the way it was supposed to (#msg-25991228).
2. TriCor failed to show a statsig benefit when added to Zocor in the ACCORD study, despite lowering triglycerides and raising HDL the way it was supposed to (#msg-47808450).
3. Niaspan showed no clinical benefit when added to Zocor in the AIM-HIGH study, despite raising HDL the way it was supposed to (#msg-63617748).
We have enemy action.
*From Goldfinger.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.